303 related articles for article (PubMed ID: 33475498)
21. Do Symptoms and Serum Calcium Levels Affect the Results of Surgical Treatment of Primary Hyperparathyroidism?
Yu Q; Liu K; Ma D; Xie C; Wu Y; Dai W; Jiang H
Biomed Res Int; 2019; 2019():2150159. PubMed ID: 31355250
[TBL] [Abstract][Full Text] [Related]
22. Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients.
Yener Ozturk F; Erol S; Canat MM; Karatas S; Kuzu I; Dogan Cakir S; Altuntas Y
Endocr J; 2016; 63(2):111-8. PubMed ID: 26581584
[TBL] [Abstract][Full Text] [Related]
23. Primary hyperparathyroidism.
Silva BC; Cusano NE; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):593-607. PubMed ID: 30449543
[TBL] [Abstract][Full Text] [Related]
24. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
[TBL] [Abstract][Full Text] [Related]
26. High Rate of Occult Urolithiasis in Normocalcemic Primary Hyperparathyroidism.
Lemos ALP; Andrade SRL; Pontes LLH; Teixeira PMC; Bandeira E; Bandeira LC; Bandeira F
Kidney Blood Press Res; 2019; 44(5):1189-1195. PubMed ID: 31542783
[TBL] [Abstract][Full Text] [Related]
27. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record.
Press DM; Siperstein AE; Berber E; Shin JJ; Metzger R; Monteiro R; Mino J; Swagel W; Mitchell JC
Surgery; 2013 Dec; 154(6):1232-7; discussion 1237-8. PubMed ID: 24383100
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism.
Minisola S; Arnold A; Belaya Z; Brandi ML; Clarke BL; Hannan FM; Hofbauer LC; Insogna KL; Lacroix A; Liberman U; Palermo A; Pepe J; Rizzoli R; Wermers R; Thakker RV
J Bone Miner Res; 2022 Nov; 37(11):2315-2329. PubMed ID: 36245271
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of primary hyperparathyroidism among patients with low bone mass.
Misiorowski W; Zgliczyński W
Adv Med Sci; 2012; 57(2):308-13. PubMed ID: 23314564
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
[TBL] [Abstract][Full Text] [Related]
32. Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects.
Invernizzi M; Carda S; Righini V; Baricich A; Cisari C; Bevilacqua M
Eur J Endocrinol; 2012 Oct; 167(4):491-7. PubMed ID: 22872468
[TBL] [Abstract][Full Text] [Related]
33. [Primary hyperparathyroidism - new clinical forms of the disease].
Zajíčková K
Vnitr Lek; 2017; 63(9):604-608. PubMed ID: 29120658
[TBL] [Abstract][Full Text] [Related]
34. Normocalcemic primary hyperparathyroidism.
Cusano NE; Cetani F
Arch Endocrinol Metab; 2022 Nov; 66(5):666-677. PubMed ID: 36382756
[TBL] [Abstract][Full Text] [Related]
35. An overview of normocalcemic primary hyperparathyroidism.
Pawlowska M; Cusano NE
Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):413-21. PubMed ID: 26512768
[TBL] [Abstract][Full Text] [Related]
36. The value of parathyroid scintigraphy on lesion detection in patients with normocalcemic primary hyperparathyroidism.
Gungor S; Dede F; Can B; Keskin H; Aras M; Ones T; Erdil TY; Turoglu HT
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021 Jun; ():. PubMed ID: 34172427
[TBL] [Abstract][Full Text] [Related]
37. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
[TBL] [Abstract][Full Text] [Related]
38. The association of primary hyperparathyroidism with pancreatitis.
Bai HX; Giefer M; Patel M; Orabi AI; Husain SZ
J Clin Gastroenterol; 2012 Sep; 46(8):656-61. PubMed ID: 22874807
[TBL] [Abstract][Full Text] [Related]
39. Comparison of normocalcemic versus hypercalcemic primary hyperparathyroidism in a hypercalciuric renal stone population.
Halimi C; Bor C; Chieze R; Saint-Jacques C; Périé S; Wagner I; Talbot JN; Montravers F; Letavernier E; Buob D; Daudon M; Frochot V; Haymann JP
J Clin Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38497124
[TBL] [Abstract][Full Text] [Related]
40. Normocalcemic primary hyperparathyroidism in patients with recurrent kidney stones: pathological analysis of parathyroid glands.
Yang AH; Hsu CW; Chen JY; Tseng LM; Won GS; Lee CH
Virchows Arch; 2006 Jul; 449(1):62-8. PubMed ID: 16670929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
